TCM-Derived Natural Compounds Targeting the Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease: Gut–Liver Axis Mechanisms, Safety Considerations, and Translational Challenges

Huailin Deng, Ruiqiu Zhang

Open source

DOI
10.3390/metabo16050342
Published
2026-05-19
Container
Metabolites
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/metabo16050342,
  title = {TCM-Derived Natural Compounds Targeting the Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease: Gut–Liver Axis Mechanisms, Safety Considerations, and Translational Challenges},
  author = {Huailin Deng and Ruiqiu Zhang},
  year = {2026},
  journal = {Metabolites},
  doi = {10.3390/metabo16050342},
  url = {https://doi.org/10.3390/metabo16050342}
}

RIS

TY  - JOUR
TI  - TCM-Derived Natural Compounds Targeting the Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease: Gut–Liver Axis Mechanisms, Safety Considerations, and Translational Challenges
AU  - Huailin Deng
AU  - Ruiqiu Zhang
PY  - 2026
JO  - Metabolites
DO  - 10.3390/metabo16050342
UR  - https://doi.org/10.3390/metabo16050342
ER  - 

APA

Deng, H., & Zhang, R. (2026). TCM-Derived Natural Compounds Targeting the Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease: Gut–Liver Axis Mechanisms, Safety Considerations, and Translational Challenges. Metabolites. https://doi.org/10.3390/metabo16050342

Source records